Literature DB >> 7541733

The treatment of Wegener's granulomatosis.

R A DeRemee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7541733      PMCID： PMC1553553          DOI： 10.1111/j.1365-2249.1995.tb06158.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  31 in total

Review 1.  Plasma exchange in systemic vasculitis.

Authors:  A J Rees; C D Pusey
Journal:  Neth J Med       Date:  1990-04       Impact factor: 1.422

2.  Cyclosporin in Wegener granulomatosis.

Authors:  F Gremmel; W Druml; P Schmidt; W Graninger
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

3.  Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients.

Authors:  T J Stillwell; R C Benson
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

4.  Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study.

Authors:  D Steppat; W L Gross
Journal:  Klin Wochenschr       Date:  1989-07-03

5.  Methotrexate therapy of Wegener's granulomatosis.

Authors:  R L Capizzi; J R Bertino
Journal:  Ann Intern Med       Date:  1971-01       Impact factor: 25.391

6.  Combined corticosteroid and azathioprine therapy in 2 patients with Wegener's granulomatosis.

Authors:  W L Norton; W Suki; S Strunk
Journal:  Arch Intern Med       Date:  1968-06

7.  Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.

Authors:  G S Hoffman; R Y Leavitt; T A Fleisher; J R Minor; A S Fauci
Journal:  Am J Med       Date:  1990-10       Impact factor: 4.965

8.  Wegener's granulomatosis--use of cyclosporin-A: a case report.

Authors:  N Harley; B Ihle
Journal:  Aust N Z J Med       Date:  1990-02

Review 9.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

10.  Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre.

Authors:  J W Tervaert; M G Huitema; R J Hené; W J Sluiter; T H The; G K van der Hem; C G Kallenberg
Journal:  Lancet       Date:  1990-09-22       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.